Summit Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $349k | 134k | 2.61 |
| 2023-09-30 | $249k | 133k | 1.87 |
| 2023-06-30 | $319k | 127k | 2.51 |
| 2022-03-31 | $37k | 15k | 2.45 |
| 2021-12-31 | $34k | 13k | 2.65 |
| 2021-09-30 | $67k | 13k | 4.99 |
| 2021-06-30 | $93k | 13k | 7.43 |